{name}
{subtitle}
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
city
~30 mi. (Peterborough, United Kingdom, +160 more cities)
facility
Peterborough City Hospital
condition
Fallopian Tube Carcinoma, +2 more conditions
drug type
chemotherapy, +1 more type
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~43 mi. (Cottingham, United Kingdom, +176 more cities)
facility
Castle Hill Hospital-Academic Oncology ( Site 2252)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)
city
~43 mi. (Cottingham, United Kingdom, +70 more cities)
facility
Castle Hill Hospital ( Site 0910)
drug
lenvatinib, +1 more drug
drug type
immunotherapy, +1 more type
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~46 mi. (Nottingham, United Kingdom, +199 more cities)
facility
Nottingham University Hospitals NHS Trust ( Site 0756)
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)
city
~46 mi. (Nottingham, United Kingdom, +127 more cities)
facility
Nottingham City Hospital ( Site 2907)
drug
lenvatinib, +1 more drug
drug type
immunotherapy, +1 more type
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
city
~46 mi. (Nottingham, United Kingdom, +126 more cities)
facility
Nottingham University Hospitals NHS Trust ( Site 0476)
drug
FOLFOX regimen, +3 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
city
~46 mi. (Nottingham, United Kingdom, +92 more cities)
facility
Nottingham University Hospital NHS Trust ( Site 0250)
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types